255 related articles for article (PubMed ID: 17634839)
41. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Wu CD; Jackson CL; Medeiros LJ
Am J Clin Pathol; 1996 Mar; 105(3):277-85. PubMed ID: 8602607
[TBL] [Abstract][Full Text] [Related]
42. Establishment and characterization of a villous lymphoma cell line from splenic B-cell lymphoma.
Inokuchi K; Abo J; Takahashi H; Miyake K; Inokuchi S; Dan K; Nomura T
Leuk Res; 1995 Nov; 19(11):817-22. PubMed ID: 8551798
[TBL] [Abstract][Full Text] [Related]
43. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study.
Troussard X; Mauvieux L; Radford-Weiss I; Rack K; Valensi F; Garand R; Vekemans M; Flandrin G; Macintyre EA
Br J Haematol; 1998 Jun; 101(4):712-21. PubMed ID: 9674745
[TBL] [Abstract][Full Text] [Related]
44. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?
Traverse-Glehen A; Baseggio L; Bauchu EC; Morel D; Gazzo S; Ffrench M; Verney A; Rolland D; Thieblemont C; Magaud JP; Salles G; Coiffier B; Berger F; Felman P
Blood; 2008 Feb; 111(4):2253-60. PubMed ID: 18042795
[TBL] [Abstract][Full Text] [Related]
45. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).
Baseggio L; Traverse-Glehen A; Callet-Bauchu E; Morel D; Magaud JP; Berger F; Salles G; Felman P
Hematol Oncol; 2011 Mar; 29(1):47-51. PubMed ID: 20677173
[TBL] [Abstract][Full Text] [Related]
46. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958
[TBL] [Abstract][Full Text] [Related]
47. Histopathological audit of splenectomies received at a cancer hospital.
Gujral S; Lad P; Subramanian PG; Shet TM; Epari S; Laskar S; Muckaden M; Menon H; Sengar M; Nair R
Indian J Pathol Microbiol; 2011; 54(3):487-96. PubMed ID: 21934208
[TBL] [Abstract][Full Text] [Related]
48. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
49. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal lymphocytosis with villous lymphocytes: a chronic lymphoproliferative disease of CD11c+ B-cells.
Bassan R; Neonato MG; Abbate M; Motta T; Barbui T; Rambaldi A
Leukemia; 1991 Sep; 5(9):799-806. PubMed ID: 1682536
[TBL] [Abstract][Full Text] [Related]
51. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
[TBL] [Abstract][Full Text] [Related]
52. Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; François S; Panelatti G; Valensi F; Grosbois B; Misset JL; Varet B; Troussard X
Leuk Lymphoma; 2000 Dec; 40(1-2):113-7. PubMed ID: 11426611
[TBL] [Abstract][Full Text] [Related]
53. The histopathology of splenic lymphoma with villous lymphocytes.
Isaacson PG; Matutes E; Burke M; Catovsky D
Blood; 1994 Dec; 84(11):3828-34. PubMed ID: 7949139
[TBL] [Abstract][Full Text] [Related]
54. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
55. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
56. Splenic lymphoma with villous lymphocytes with CD5+, CD11c+ B-cell phenotype.
Miyawaki S; Machii T; Hirabayashi H; Sakura T; Shiozaki H; Yashiro K; Murakami H; Tsuchiya J; Kashiwabara K; Kitani T
Intern Med; 1993 Jun; 32(6):472-5. PubMed ID: 7694693
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
58. [Splenic lymphoma with villous lymphocytes and complex chromosomal abnormality].
Hamamoto K; Ohno T; Ogawa H; Date M; Kimura T; Fukuhara S
Rinsho Ketsueki; 1997 Jun; 38(6):544-9. PubMed ID: 9248332
[TBL] [Abstract][Full Text] [Related]
59. Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification.
Schwonzen M; Pohl C; Steinmetz T; Seckler W; Vetten B; Thiele J; Wickramanayake D; Diehl V
Br J Haematol; 1993 Feb; 83(2):232-9. PubMed ID: 8457472
[TBL] [Abstract][Full Text] [Related]
60. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]